Latest filing published 25 Nov 2020 for GenMark Diagnostics, Inc., €28k. Read the official filing
All filings by Eric Stier on record concern GenMark Diagnostics, Inc. We count 77 filings; the first trade dates from 21 January 2016 and the latest from 24 November 2020.
Every open-market trade on record is a sale: 66 sales worth €1.6M. Outside the open market, there are 6 share grants and 5 option exercises. Since January 2020: no purchases and 11 sales on the market.
Most recently, on 25 November 2020, the filings show an open-market sale worth €28k in GenMark Diagnostics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 77 declarations